The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 25, 2021
Filed:
Jan. 09, 2018
Applicant:
Isofol Medical Ab, Gothenburg, SE;
Inventors:
Per L. Lindberg, Gothenburg, SE;
Anders Vedin, Gothenburg, SE;
Gunnel E. Sundén, Gothenburg, SE;
Bengt Gustavsson, Västra Froelunda, SE;
Assignee:
Isofol Medical AB, Gothenburg, SE;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 31/282 (2006.01); A61K 31/4545 (2006.01); A61K 31/4745 (2006.01); A61K 31/513 (2006.01); A61K 31/555 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01); C07K 16/22 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0019 (2013.01); A61K 31/282 (2013.01); A61K 31/4545 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/555 (2013.01); A61K 39/395 (2013.01); A61K 39/39558 (2013.01); A61P 35/00 (2018.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 16/22 (2013.01);
Abstract
The present invention relates to the treatment of solid tumors in humans such as cancer, especially colorectal cancer (CRC), which involves administering the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy.